Filing Details

Accession Number:
0001628908-23-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-05 16:23:51
Reporting Period:
2023-06-01
Accepted Time:
2023-06-05 16:23:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628908 Evolent Health Inc. EVH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204938 J Frank Williams C/O Evolent Health, Inc.
800 North Glebe Road, Suite 500
Arlington VA 22203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-06-01 19,060 $6.87 838,872 No 4 M Direct
Class A Common Stock Acquisiton 2023-06-01 90,940 $10.27 929,812 No 4 M Direct
Class A Common Stock Disposition 2023-06-01 9,091 $29.27 920,721 No 4 S Direct
Class A Common Stock Disposition 2023-06-01 9,969 $29.75 910,752 No 4 S Direct
Class A Common Stock Disposition 2023-06-01 41,914 $29.26 868,838 No 4 S Direct
Class A Common Stock Disposition 2023-06-01 49,026 $29.74 819,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class A Common Option (right to buy) Disposition 2023-06-01 19,060 $0.00 19,060 $6.87
Class A Common Stock Class A Common Option (right to buy) Disposition 2023-06-01 90,940 $0.00 90,940 $10.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-01 No 4 M Direct
17,250 2026-03-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 66,064 Indirect See footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022.
  2. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.63 to $29.62, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.63 to $29.83, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.60 to $29.59, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.86, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
  8. The Class A Common Stock Options exercised vested on February 1, 2019.
  9. The Class A Common Stock Options exercised vested on March 1, 2017, March 1, 2018, March 1, 2019, and March 1, 2020.